←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS89%
R&D + SG&A0%
Op Margin13%
FINANCIAL HEALTH
REVENUE
$39.1B
Growth
93%
Gross M.
11%
P/E
11.5
EV/EBITDA
10.1
Net M.
6%
FCF M.
-21%
D/E
0.76
Op M.
13%
PLUG INTO YOUR DCF
Historical growth
45.8%
Analyst 5y growth
—
Forward P/E
6.9
PEG ratio
0.90
Trailing EPS
$3.20
Forward EPS
$5.30
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
LOWA mechanical base-case DCF (default assumptions) implies 1169% upside to $464.14 — take this as a rough, unverified estimate, not a target.
LOWDebt/equity of 0.76 — conservative balance sheet.
MEDRevenue growing 93% YoY — the multiple depends on this pace continuing; deceleration is a real risk.
🐂 BULL
SMCI shows revenue grew +93.2% YoY, 13% operating margin, 21% ROE — a business converting growth into real profit.
🐻 BEAR
At a P/E of 11.5 and EV/EBITDA of 10.1, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.